Saturday, October 3, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· January 27, 2026

S&P Cotality Case-Shiller Index Reports Annual Gain In November 2025

View original at finance.yahoo.com
S&P Cotality Case-Shiller Index Reports Annual Gain In November 2025 The S&P Cotality Case-Shiller U.S. National Home Price NSA Index posted a 1.4% annual gain for November, in line with the previous month…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • S&P DJI will continue to provide updates to the Detroit index values for the month(s) with missing sale transactions data

    80% confidence
  • Chicago leads all cities for a second consecutive month with a 5.7% year-over-year price increase, followed by New York at 5.0% and Cleveland at 3.4%

    80% confidence
  • National home prices were only 1.4% higher than a year ago, unchanged from October's annual pace and still near the weakest showing since mid-2023

    80% confidence
  • November's results confirm that the housing market has entered a period of tepid growth

    80% confidence
  • On a non-seasonally adjusted basis, 15 of the 20 major metro areas saw prices decline from October, versus 16 declines in the previous month

    80% confidence
  • Tampa home prices are 3.9% lower than a year ago, the steepest decline among the 20 cities, extending that market's 13-month streak of annual drops

    80% confidence
  • Thirty-year loan rates hovered in the mid-6% range during November, weighing on affordability even as they eased slightly from recent peaks

    80% confidence
  • The S&P Cotality Case-Shiller Indices could be revised for the prior 24 months, based on the receipt of additional source data

    80% confidence
  • Current home price growth (1.4%) is less than half of the 3.7% annual price increase recorded in November 2024

    80% confidence
  • After accounting for typical seasonal slowing, the National Index inched up just 0.4% for the month, indicating that price momentum remains muted

    80% confidence
  • Inflation has erased most nominal gains, leaving home values essentially flat in real terms

    80% confidence
  • Consumer inflation cooled to 2.7% in November 2025, dipping below 3% for the first time since August and aligning with its average pace over the prior 12 months

    80% confidence
  • Home price growth trails inflation by roughly 1.3 percentage points, meaning real home values have effectively edged down over the past year

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com